retatrutide triple agonist glp-1 gip glucagon ly3437943 Retatrutide's mechanisms of action Retatrutide vs Semaglutide: Triple vs

10.1038/s42255-021-00344-4 [DOI] [PMC free article] [PubMed] [Google Scholar] Brierley, D

Basal rates of gluconeogenesis ( 2 H 2 O), glucose production ([6,6- 2 H 2 ]glucose) and whole-body lipolysis ([ 2 H 5 ]glycerol) were measured after an overnight fast on study day 2

Archived from the original on 28 January 2023

When to contact your GP or diabetes team : Persistent vomiting preventing fluid intake Severe abdominal pain, especially if radiating to the back (possible pancreatitis) Right upper abdominal pain, fever or jaundice (possible gallbladder problems) Signs of dehydration (dark urine, dizziness, reduced urination) Unexplained hypoglycaemia if on combination therapy New or worsening visual symptoms (especially if you have diabetic retinopathy) Allergic reactions (rash, swelling, breathing difficulties) Most patients tolerate GLP-1 medications well once past the initial adjustment period

This study does not say GLP-1 medications are proven safe throughout pregnancy